Next-gen insulin pump from Insulet receives 510(k) clearance

12/16/2012 | American City Business Journals

The FDA has cleared Insulet to market a next-generation version of its OmniPod system, which is used to deliver insulin in diabetes patients. The company said the newly cleared device, which is one-quarter lighter and one-third smaller than the original version launched in 2005, is expected to arrive in the U.S. in March.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY